Trends in Molecular Medicine
OpinionMCL1 as a Therapeutic Target in Parkinson's Disease?
Section snippets
Exposing the Intrinsic Vulnerability of Midbrain Dopamine Neurons
Underlying the motor symptoms of Parkinson's disease (PD) is the loss of dopaminergic neurons that project from the substantia nigra (SN; see Glossary) to the striatum. These neurons regulate voluntary movement, and their loss leads to tremor, progressive rigidity, loss of postural stability, and bradykinesia [1]. Current treatments are aimed at relieving clinical symptoms. There is no cure. The 'gold standard' in the treatment of PD is oral supplementation with L-DOPA
The Importance of Bcl2 Proteins in Dopaminergic Neurons
In one of the first studies addressing the role of Bcl2 factors (a list of the best-known Bcl2 factors is given in Table 1) in mouse dopamine neurons, a protective effect of Bcl2 expressed from the promoter of the gene (Th) encoding tyrosine hydroxylase (Th) was shown. Ectopic expression of Bcl2 resulted in an increased number of dopaminergic neurons and also protected against cell loss following quinolinic acid administration in the striatum, thus providing a proof-of-principle that Bcl2
Mcl1 as a Survival Factor in Dopamine Neurons
Previous studies have shown that Mcl1 is highly expressed in neurons of the developing brain and that its expression drops dramatically in the adult, suggesting a role of lesser importance at this stage [22]. In contrast to Mcl1, the prosurvival Bcl2 factor Bcl-xL remains highly expressed in adult neurons and has been shown to be crucial for the survival of cortical neurons 22, 23. However, despite its overall low expression in the adult brain, recent studies support an important role for Mcl1
Targeting Mcl1: The Ubiquitin Proteasome System, E3 Ubiquitin Ligases, and Deubiquitinases
Mcl1 harbors a large N-terminal region packed with regulatory motifs. Interestingly, many of these motifs influence the stability of Mcl1. Mcl1 is a short-lived protein and is rapidly degraded, which is attributed to the ubiquitin proteasome system 27, 28. Depending on the cell type studied, Mcl1 half-life ranges from 1 h to 5 h. Human MCL1 contains 12 lysine residues, of which five are described to be extensively involved in its degradation: K5, K40, K136, K194, and K197 [29]. By comparison,
Targeting Mcl1 with Small Molecules and Peptides as a Therapeutic Approach
The BCL2 family has been the focus of drug discovery efforts in oncology, with the objective of inhibiting the protective guardian BCL2 family members to induce apoptosis in tumors. To our knowledge, no drug discovery or rational drug design effort has aimed to achieve the opposite – the selective enhancement of antiapoptotic BCL2 ‘guardian’ function to protect death-prone cells.
Concluding Remarks
Halting the progressive loss of dopaminergic neurons in the SN is a major challenge in PD research. Causative mutations have been identified in a minor fraction of PD patients, but the majority of PD cases remain idiopathic with an identical end-result: neurodegeneration. By interfering with crucial components necessary for cell death, a generalized method for halting neurodegeneration in PD could be realized. Accumulating evidence supports a role for BCL2 proteins and mitochondria-dependent
Acknowledgments
This work has been supported by Stichting ParkinsonFonds, The Netherlands.
Glossary
- Agonists
- chemicals that invoke an action response, in other words activators. By contrast, antagonists inhibit a response.
- Bioenergetics
- pathways which involve energy in organisms, such as growth, development, and metabolism. ATP is the main energy source used during these processes.
- Bradykinesia
- a slowness of movement that is characteristic of Parkinson’s disease (PD) symptoms.
- Caspases
- specialized proteins that are known for their cleavage activity in the apoptosis pathway.
- Degron
- the part of a
References (70)
- et al.
Parkinson’s disease: mechanisms and models
Neuron
(2003) - et al.
The BCL2 code to dopaminergic development and Parkinson’s disease
Trends Mol. Med.
(2013) The BCL-2 family reunion
Mol. Cell
(2010)Parkin sensitizes toward apoptosis induced by mitochondrial depolarization through promoting degradation of Mcl-1
Cell Rep.
(2014)Bcl-2 family proteins participate in mitochondrial quality control by regulating parkin/PINK1-dependent mitophagy
Mol. Cell
(2014)BNIP3 suppresses PINK1 proteolytic cleavage to promote mitophagy
J. Biol. Chem.
(2016)Developmental regulation of mitochondrial apoptosis by c-Myc governs age- and tissue-specific sensitivity to cancer therapeutics
Cancer Cell
(2017)Decreased Mcl-1 protein level in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice
Brain Res.
(2018)Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons
Curr. Biol.
(2015)Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis
Cell
(2005)